Back to Rankings

ASND

Ascendis A/SF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
ASND vs peer average
15/100
ASND vs. peer average (F vs. B)
Grade spread
A 4 · B 1 · C 5 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

AMGN is the first available peer comparator.

Major biotech with broad commercial muscle and experience integrating acquisitions — relevant for deal/acquirer appetite.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAMGNAmgen
ASND
Ascendis A/S
AMGN
Amgen
Grade
F
C
Momentum
55
36
Value
41
64
Sentiment
0
47
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed

Grade position vs AMGN

ASND / AMGN
Grade Position
Below peers
ASND vs. peer average (F vs. B)
15/100
Momentum
55
ASND
Value
41
AMGN
Sentiment
0
AMGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ASND
1
AMGN
AMGN
C
60/100
-2
2
LLY
LLY
A
100/100
-4
3
NVO
NVO
A
100/100
-4
4
MEDP
Medpace Holdings Inc Common
C
60/100
-2
5
BBIO
BridgeBio Pharma Inc Common
C
60/100
-2
AMGN is the first peer returned for this comparison set.